Answers are grounded in this paper and cite their sources.
Testing multiple inflammatory markers simultaneously does not increase ability to rule out disease and should generally be avoided. CRP has marginally superior diagnostic accuracy for infections, and is equivalent for autoimmune conditions and cancers, so should generally be the first-line test.
No takes yet. Share an insight, caveat, or question.
Watson et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: